Get started
Author

Enxu Zhao

Observed names: E. Zhao, ENXU ZHAO
OpenAlex ID: A5064567737
Factors associated with abnormal spirometry among HIV-infected individuals
2015 · M. Bradley Drummond, Laurence Huang, et al. · AIDS · 51
Associations of cytokines, sleep patterns, and neurocognitive function in youth with HIV infection
2012 · Samuel B. Foster, Ming Lu, et al. · Clinical Immunology · 49
Efficacy and tolerability of repository corticotropin injection in patients with persistently active SLE: results of a phase 4, randomised, controlled pilot study
2016 · Richard Furie, Margaret Mitrane, et al. · Lupus Science & Medicine · 34
PDF
A Phase 1, First-in-Human, Dose-Escalation Study of MGD024, a CD123 x CD3 Bispecific Dart® Molecule, in Patients with Relapsed or Refractory CD123-Positive (+) Hematologic Malignancies
2022 · Eric S. Winer, Michael Maris, et al. · Blood · 25
Repository Corticotropin Injection for Persistently Active Systemic Lupus Erythematosus: Results from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
2020 · Anca D. Askanase, Enxu Zhao, et al. · Rheumatology and Therapy · 20
PDF
Patient-Reported Outcomes from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Repository Corticotropin Injection (Acthar® Gel) for Persistently Active Systemic Lupus Erythematosus
2021 · Anca D. Askanase, George J. Wan, et al. · Rheumatology and Therapy · 15
PDF
Repository corticotropin injection in patients with persistently active SLE requiring corticosteroids: post hoc analysis of results from a two-part, 52-week pilot study
2017 · Richard A Furie, Margaret Mitrane, et al. · Lupus Science & Medicine · 15
PDF
Results from a multicenter, randomized, double‐blind, placebo‐controlled study of repository corticotropin injection for multiple sclerosis relapse that did not adequately respond to corticosteroids
2022 · Daniel Wynn, Lawrence Goldstick, et al. · CNS Neuroscience & Therapeutics · 9
PDF
A Prospective Observational Registry of Repository Corticotropin Injection (Acthar® Gel) for the Treatment of Multiple Sclerosis Relapse
2020 · Jeffrey Kaplan, Tamara Miller, et al. · Frontiers in Neurology · 8
PDF
Post Hoc Biomarker Analyses from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Repository Corticotropin Injection (Acthar® Gel) for Persistently Active Systemic Lupus Erythematosus
2021 · Anca D. Askanase, Dale Wright, et al. · Rheumatology and Therapy · 6
PDF
Acthar Gel (repository corticotropin injection) for persistently active SLE: study design and baseline characteristics from a multicentre, randomised, double-blind, placebo-controlled trial
2020 · Anca D Askanase, Enxu Zhao, et al. · Lupus Science & Medicine · 6
PDF
757 A phase 1/1b dose escalation and cohort expansion study of MGC018 in combination with lorigerlimab in patients with advanced solid tumors (AST)
2022 · John Powderly, Patrick Kaminker, et al. · Journal for ImmunoTherapy of Cancer · 5
PDF
Repository Corticotropin Injection Improves Quality Metrics in an Observational Study of Multiple Sclerosis Relapse
2021 · Jeffrey Kaplan, Tamara Miller, et al. · Neurodegenerative Disease Management · 3
Post hoc analysis using PRO-ACT database to evaluate Repository Corticotropin Injection (H.P. Acthar® Gel) as a potential treatment for ALS (P5.327)
2018 · Susan VanMeter, Patrice Becker, et al. · Neurology · 2
THU0307 Repository Corticotropin Injection (RCI) Attenuates Disease Activity in Patients with Persistently Active Systemic Lupus Erythematosus (SLE) Requiring Corticosteroids: Results from A 44-Week Open-Label Extension Study
2016 · P. Becker, R. Furie, et al. · Annals of the Rheumatic Diseases · 2
Vobramitamab duocarmazine, an anti–B7‐H3 antibody–drug conjugate, in patients with advanced solid tumors: Final results of a phase 1 cohort expansion
2026 · Eugene Shenderov, Manish R. Sharma, et al. · Cancer · 1
A Phase 4, Multicenter, Randomized, Double-blind, Placebo-controlled Exploratory Study to Assess the Efficacy and Safety of Repository Corticotropin Injection in Subjects With Pulmonary Sarcoidosis (pulsar): Study Design and Baseline Characteristics
2021 · ROBERT BAUGHMAN, MEHDI MIRSAEIDI, et al. · CHEST Journal · 1
PDF
Correction to: Repository Corticotropin Injection for Persistently Active Systemic Lupus Erythematosus: Results from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
2021 · Anca D. Askanase, Enxu Zhao, et al. · Rheumatology and Therapy · 1
PDF
Correction: Targeting mitochondrial oxidative stress with MitoQ reduces NET formation and kidney disease in lupus-prone MRL-lpr mice
2020 · Anca D Askanase, Enxu Zhao, et al. · Lupus Science & Medicine · 1
PDF
A Prospective Observational Registry Study of Repository Corticotropin Injection for the Treatment of Multiple Sclerosis Relapse (4503)
2020 · Jeffrey Kaplan, Tamara Miller, et al. · Neurology
Fri0183 Study Design for a Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Repository Corticotropin Injection in Patients With Systemic Lupus Erythematosus Despite Moderate-dose Corticosteroids
2019 · Anca Askanase, Enxu Zhao, et al. · Annals of the Rheumatic Diseases
PDF
Rationale and Design for a Multicenter, Double-blind, Placebo-Controlled Study to Assess the Efficacy and Safety of H.P. Acthar® Gel in the Treatment of Subjects with Amyotrophic Lateral Sclerosis (P5.331)
2018 · Susan VanMeter, Patrice Becker, et al. · Neurology
Using SAS ® to Handle HL7 Messages in A Health Information Exchange
2009 · Enxu Zhao, Kathryn J. Schmit
Works count: 25
Citation count: 255
H-index: 8
I10-index: 8
Year
Topic
Type